Comparative Study of Serum Magnesium Levels in Diabetic Patients with And Without Microvascular Complications In A Tertiary Care Centre
Main Article Content
Keywords
Serum magnesium, Type 2 diabetes, Microvascular complications, HbA1c, Diabetes duration, Neuropathy
Abstract
Background: It has been shown in several research that type 2 diabetes mellitus (DM) and its consequences with hypomagnesemia are related. Given that retinopathy, neuropathy, and nephropathy have been linked to hypomagnesemia in recent studies, it is advisable to routinely evaluate magnesium in this patient group and treat hypomagnesemia whenever possible. To compare type 2 diabetics' blood magnesium levels with microvascular problems was the goal of this study.
Methods: This research is a cross-sectional analytical study. About 114 diabetic patients from outpatient clinics, wards and intensive care unit were recruited from Department of General Medicine, Sri Balaji Medical College and Hospital, Crumpet, Chennai. The study population are further divided into two groups. Fifty-seven people with diabetes with microvascular complications (group I) have diabetes with no microvascular complications (group II). Clinical and physical examinations were done on all patients.
Results: Most diabetic patients (37%) aged 51 to 60 years, 54% male and 46% female. Approximately 26% of recruited patients had diabetes < 5 years, 44% were on insulin treatments, and 56% were oral hypoglycaemic agents. 57 diabetic people that have microvascular issues. Magnesium levels in the blood are noticeably greater in diabetics with microvascular difficulties than in those without issues. Between these two groups, no notable biochemical differences were discovered. Diabetic neuropathy is more likely to occur in patients who have had diabetes for a longer length of time.
Conclusions: We conclude that level of serum magnesium levels was found to be abnormally low with increasing diabetes duration along with microvascular complications. Type 2 diabetes patients who had hypomagnesemia were more likely to have long-term and microvascular problems.
References
2. Resnick LM, Gupta RK, Bhargava KK, Hgruenspan H, Alderman MH, Laragh J. Magnesium deficiency in diabetes. Hypertension. 1991; 17:951–7.
3. Ghose B, Ide S. Hypomagnesemia and type 2 diabetes mellitus: A review of the literature. Austin J Nutri Food Sci. 2014;2:1025.
4. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens. 1997; 10: 346-355.
5. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clinical diabetes. 2008 1;26:77-82.
6. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL.Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The atherosclerosis risk in communities study. Arch Intern Med. 1999; 159:2151–9.
7. Arpaci D, Tocoglu AG, Ergenc H, Korkmaz S, Ucar A, Tamer A. Associations of serum Magnesium levels with diabetes mellitus and diabetic complications. Hippokratia. 2015;19:153.
8. Erasmus RT, Olukoga AO, Alanamu RA, Adewoye HO, Bojuwoye B. Plasma magnesium and retinopathy in black African diabetics. Trop Geogr Med. 1989; 41:234–7.
9. Rodŕı́ guez-Morán M, Guerrero-Romero F. Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes. Archives of medical research. 2001;32:300-3.
10. Pham PCT, Pham PMT, Pham SV, Miller JM, Pham PTT. Hypomagnesemia in Patients with Type 2 Diabetes Clin J Am Soc Nephrol 2007; 2: 366–73.
11. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37 Suppl 1:S81–S90.
12. Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes. 2009;10 Suppl 12:3–12.
13. Galtier F. Definition, epidemiology, risk factors. Diabetes Metab. 2010;36:628–651.
14. Maitra A, Abbas AK. Endocrine system. In: Kumar V, Fausto N, Abbas AK (eds). Robbins and Cotran Pathologic basis of disease (7th ed) 2005. Philadelphia, Saunders; 1156-122.
15. De Valk HW, Verkaaik R, van Rijn HJ, Geerdink RA, Struyvenberg A. Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients. Diabet Med 1998;15:503–7.
16. Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomised double-blind controlled trial. Diabetes Care. 2003;26:1147–52.
17. Sanders GT, Huijgen HJ, Sanders R. Magnesium in disease: a review with special emphasis on the serum ionised magnesium.1999: 1011-1022
18. Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM. Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993;36:767–70.
19. Alzaid AA, Dinneen SF, Moyer TP, Rizza RA. Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 1995;80:1376–81.
20. White JR Jr, Campbell RK. Magnesium and diabetes: a review. Ann Pharmacother 1993;27:775–80.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.